Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2025
About
Suggestions
Contact Us
Hemolysis
MeSH Descriptor Data 2024
Details
Qualifiers
MeSH Tree Structures
Concepts
MeSH Heading
Hemolysis
Tree Number(s)
C23.550.403
G12.122.545
Unique ID
D006461
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D006461
Annotation
hemolysis in gel =
HEMOLYTIC PLAQUE TECHNIQUE
Scope Note
The destruction of
ERYTHROCYTES
by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
Entry Term(s)
Extravascular Hemolysis
Haemolysis
Intravascular Hemolysis
NLM Classification #
WH 150
See Also
Anemia, Hemolytic
Osmotic Fragility
Date Established
1966/01/01
Date of Entry
1999/01/01
Revision Date
2019/06/17
Allowable Qualifiers
drug effects (DE)
ethics (ES)
genetics (GE)
immunology (IM)
physiology (PH)
radiation effects (RE)
Pathological Conditions, Signs and Symptoms [C23]
Pathologic Processes [C23.550]
Acantholysis [C23.550.035]
Arrhythmias, Cardiac [C23.550.073]
Ascites [C23.550.081]
Atrial Remodeling [C23.550.113]
Azotemia [C23.550.145]
Cardiotoxicity [C23.550.161]
Channelopathies [C23.550.177]
Chromosome Aberrations [C23.550.210]
Death [C23.550.260]
Dehydration [C23.550.274]
Delayed Graft Function [C23.550.277]
Disease [C23.550.288]
Disease Attributes [C23.550.291]
Dysbiosis [C23.550.308]
Emphysema [C23.550.325]
Extravasation of Diagnostic and Therapeutic Materials [C23.550.340]
Femoracetabular Impingement [C23.550.347]
Fibrosis [C23.550.355]
Frailty [C23.550.359]
Genomic Instability [C23.550.362]
Gliosis [C23.550.369]
Granuloma [C23.550.382]
Granulomatosis, Orofacial [C23.550.384]
Growth Disorders [C23.550.393]
Hemolysis [C23.550.403]
Hemorrhage [C23.550.414]
Hyperammonemia [C23.550.421]
Hyperamylasemia [C23.550.425]
Hyperbilirubinemia [C23.550.429]
Hyperplasia [C23.550.444]
Hyperuricemia [C23.550.449]
Hypovolemia [C23.550.455]
Inflammation [C23.550.470]
Intraoperative Complications [C23.550.505]
Ischemia [C23.550.513]
Leukoaraiosis [C23.550.522]
Leukocytosis [C23.550.526]
Lithiasis [C23.550.537]
Long Term Adverse Effects [C23.550.543]
Malacoplakia [C23.550.548]
Menstruation Disturbances [C23.550.568]
Metaplasia [C23.550.589]
Muscle Weakness [C23.550.695]
Myotoxicity [C23.550.706]
Necrosis [C23.550.717]
Neointima [C23.550.722]
Neoplastic Processes [C23.550.727]
Nerve Degeneration [C23.550.737]
Ochronosis [C23.550.744]
Ossification, Heterotopic [C23.550.751]
Ototoxicity [C23.550.753]
Pigmentation Disorders [C23.550.755]
Polydipsia [C23.550.759]
Postoperative Complications [C23.550.767]
Protein Aggregation, Pathological [C23.550.770]
Respiratory Aspiration [C23.550.773]
Retropneumoperitoneum [C23.550.794]
Sclerosis [C23.550.823]
Shock [C23.550.835]
Teratogenesis [C23.550.863]
Toxic Optic Neuropathy [C23.550.877]
Ulcer [C23.550.891]
Vascular Remodeling [C23.550.918]
Yang Deficiency [C23.550.945]
Yin Deficiency [C23.550.972]
Immune System Phenomena [G12]
Antigen-Antibody Reactions [G12.122]
Agglutination [G12.122.100]
Antibody Affinity [G12.122.125]
Antigenic Modulation [G12.122.140]
Binding Sites, Antibody [G12.122.232]
Cross Reactions [G12.122.281]
Hemolysis [G12.122.545]
Immunologic Capping [G12.122.612]
Passive Cutaneous Anaphylaxis [G12.122.754]
Rh Isoimmunization [G12.122.780]
Expand All
Collapse All
Hemolysis
Preferred
Concept UI
M0010143
Scope Note
The destruction of
ERYTHROCYTES
by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
Terms
Hemolysis
Preferred Term
Term UI
T019505
Date
01/01/1999
LexicalTag
NON
ThesaurusID
NLM (1966)
Haemolysis
Term UI
T000956622
Date
05/01/2019
LexicalTag
NON
ThesaurusID
NLM (2020)
Intravascular Hemolysis
Narrower
Concept UI
M000616279
Terms
Intravascular Hemolysis
Preferred Term
Term UI
T000897970
Date
03/31/2016
LexicalTag
NON
ThesaurusID
NLM (2017)
Extravascular Hemolysis
Narrower
Concept UI
M000616280
Terms
Extravascular Hemolysis
Preferred Term
Term UI
T000897971
Date
03/31/2016
LexicalTag
NON
ThesaurusID
NLM (2017)
page delivered in 0.202s